Lung cancer, elderly and immune checkpoint inhibitors.

@article{Casaluce2018LungCE,
  title={Lung cancer, elderly and immune checkpoint inhibitors.},
  author={Francesca Casaluce and Assunta Sgambato and Paolo Maione and Alessia Spagnuolo and Cesare Gridelli},
  journal={Journal of thoracic disease},
  year={2018},
  volume={10 Suppl 13},
  pages={
          S1474-S1481
        }
}
Lung cancer is predominantly a disease of the elderly with about 50% of diagnoses in patients aged ≥70 years and about 14% in those older than 80. Medical and physiological characteristics of elderly cancer patients make the choice of their better treatment more challenging. Furthermore, aging is accompanied by the so called "immunosenescence" phenomenon… CONTINUE READING